February 12, 2020
Teva Pharmaceutical reported US$16.9 billion in full year revenue in its results for the year and the quarter ended December...
October 2, 2019
The company's inhaler therapy, Trelegy Ellipta, has already been approved in the US for chronic obstructive pulmonary disease.
September 16, 2019
Lundbeck will add Alder BioPharma's potential blockbuster migraine treatment, eptinezumab, to its pipeline ahead of patent expirations.